Acinetobacter species, particularly Acinetobacter baumannii, is the first pathogen on the
critical priority list of pathogens for novel antibiotics to become a “red-alert” human …

Acinetobacter baumannii is undoubtedly one of the most successful pathogens responsible
for hospital-acquired nosocomial infections in the modern healthcare system. Due to the …

Background There is paucity of data describing the impact of COVID-19 pandemic on
antimicrobial resistance. This review evaluated the changes in the rate of multidrug resistant …

Acinetobacter baumannii (A. baumannii) is undoubtedly one of the most successful
pathogens in the modern healthcare system. With invasive procedures, antibiotic use and …

Alexander Fleming's discovery of penicillin heralded an age of antibiotic development and
healthcare advances that are premised on the ability to prevent and treat bacterial infections …

Multidrug resistant (MDR) bacteria are a global threat with many common infections
becoming increasingly difficult to eliminate. While significant effort has gone into the …

Background Antibiotic use is largely under-regulated in Egypt leading to the emergence of
resistant isolates. Carbapenems are last resort agents to treat Acinetobacter baumannii …

Resistance-nodulation-cell division multidrug efflux pumps are membrane proteins that
catalyze the export of drugs and toxic compounds out of bacterial cells. Within the …

Acinetobacter baumannii is a Gram-negative pathogen that has emerged as one of the most
highly antibiotic-resistant bacteria worldwide. Multidrug efflux within these highly drug …

The emergence of multidrug-resistant Acinetobacter baumannii is a major concern to
healthcare providers and facilities in many parts of the world. This bacterial pathogen is …